Johnson & Johnson (JNJ)
NYSE:JNJ

Johnson & Johnson (JNJ) Stock Price & Analysis

21,078 Followers

JNJ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$147.91 - $177.11
Previous Close$155.75
Volume7.68M
Average Volume (3M)22.75M
Market Cap
$375.05B
Enterprise ValueN/A
Total Cash (Recent Filing)$28.50B
Total Debt (Recent Filing)$45.60B
Price to Earnings (P/E)31.6
Beta0.31
Oct 17, 2023
4.64 (2.98%)
Share Statistics
EPS (TTM)4.94
Shares Outstanding2,598,969,594
10 Day Avg. Volume6,205,779
30 Day Avg. Volume22,750,318
Standard Deviation0.05
R-Squared0.33
Alpha0.00179
Financial Highlights & Ratios
Price to Book (P/B)-24.69
Price to Sales (P/S)15.86
Price to Cash Flow (P/CF)24.40
P/FCF Ratio30.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
Price Target Upside14.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

JNJ FAQ

What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $147.91 and its highest was $177.11 in the past 12 months.
    What is Johnson & Johnson’s market cap?
    Currently, no data Available
    When is Johnson & Johnson’s upcoming earnings report date?
    Johnson & Johnson’s upcoming earnings report date is Oct 17, 2023 which is in 17 days.
      How were Johnson & Johnson’s earnings last quarter?
      Johnson & Johnson released its earnings results on Jul 20, 2023. The company reported $2.8 earnings per share for the quarter, beating the consensus estimate of $2.617 by $0.183.
        Is Johnson & Johnson overvalued?
        According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Johnson & Johnson pay dividends?
          Johnson & Johnson pays a Quarterly dividend of $1.19 which represents an annual dividend yield of 2.92%. See more information on Johnson & Johnson dividends here
            What is Johnson & Johnson’s EPS estimate?
            Johnson & Johnson’s EPS estimate is $2.53.
              How many shares outstanding does Johnson & Johnson have?
              Johnson & Johnson has 2,408,014,200 shares outstanding.
                What happened to Johnson & Johnson’s price movement after its last earnings report?
                Johnson & Johnson reported an EPS of $2.8 in its last earnings report, beating expectations of $2.617. Following the earnings report the stock price went up 6.072%.
                  Which hedge fund is a major shareholder of Johnson & Johnson?
                  Among the largest hedge funds holding Johnson & Johnson’s share is Fisher Asset Management LLC. It holds Johnson & Johnson’s shares valued at 1B.

                    ---

                    Johnson & Johnson Stock Smart Score

                    The Johnson & Johnson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Johnson & Johnson

                    Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

                    ---

                    Top 5 ETFs holding JNJ

                    Name
                    Market Value
                    Smart Score
                    Global X S&P 500 Covered Call ETF
                    $29.92M
                    8
                    Zacks Earnings Consistent Portfolio ETF
                    $1.22M
                    8
                    Global X S&P 500 Covered Call & Growth ETF
                    $620.93K
                    8
                    ClearBridge Dividend Strategy ESG ETF
                    $581.24K
                    8
                    Global X S&P 500 Tail Risk ETF
                    $25.89K
                    8
                    Up to five ETFs with an Outperform Smart Score that hold JNJ. The ETFs are listed according to market value of JNJ within the ETF

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Pfizer
                    Amgen
                    Bristol-Myers Squibb
                    GlaxoSmithKline

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis